Skip to content

aerFree Airway Management System (AMS) 30-5001Recalls & reported problems

Sommetrics, Inc. · aerFree AMS utilizes patented aer+TM technology to simply and safely support the patency of the upper airway during medical procedures requiring mild to moderate levels of sedation. It is FDA-cleared for airway management in adults undergoing medical procedures of less than 2 hours in duration, where the patient is intended to receive mild to moderate sedation with non-propofol containing medications. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00851167007001), received between Oct 6, 2020 and Oct 6, 2020 — classified as 1 malfunction.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Blister1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 6, 2020Adverse Event Without Identified Device or Use Problem

    AN AIRWAY POSITIONING DEVICE, AERFREE AIRWAY MANAGEMENT SYSTEM (AMS), WAS APPLIED TO THE PT'S NECK AND THEN CONNECTED TO SUCTION. AT END OF PROCEDURE, THE DEVICE WAS REMOVED, AND BLISTERS WERE NOTED AT THE SITE.

    Patient problems: Blister

    MAUDE report 10634730 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page